Identifying the molecular mechanism of this effect of PLX could provide novel therapies to prevent build up and aggregation of toxic proteins by enhancing protein degradation in neurons in SCA1 and other neurodegenerative diseases. Here, ATXN1 is linked to neurodegenerative disease.